About
Frequently Asked Questions
Partners
Press
Donate
Donors
Contact
Home
Meetings
Cognitive Science Conference
Neuroethics
Beyond Belief
Stem Cell Meeting on the Mesa
Brains R Us: The Science of Educating
more »
Series
The Rightful Place
The Science Review
The Science Reader
The Science Studio
Et Cetera
Filmed Courses
12th EEGLAB Workshop
Raw Science
Home
»
Meetings
»
Industry/Academia Translational Oncology Symposium 2012
»
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies
Get the Flash Player
to see this player.
Loading the player ...
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies
Wendy Levin, Pfizer
Run Time:
16 minutes
Speakers:
Wendy Levin
Topics:
Cancer
DOWNLOAD Audio:
moorescancer-mar12-06-levin.mp3
Download
Report an issue with this video »
Industry/Academia Translational Oncology Symposium 2012
Moores Cancer Center
14 parts
March 22, 2012
Related Videos
Panel 1: Ben Spike
George Martin
Judith Campisi
Panel 1: Luke Lairson
Clinical Applications of Stem Cell Research
Topics
Stem Cells
(117)
neuroscience
(92)
education
(45)
Aging
(44)
sleep
(44)
Evolution
(40)
genetics
(37)
Cancer
(35)
Follow Us
Receive TSN updates on upcoming programs and announcements:
TSN Podcasts
Subscribe with iTunes
Or, copy and paste this URL into a podcasting tool: